1. Home
  2. PK vs ADMA Comparison

PK vs ADMA Comparison

Compare PK & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Hotels & Resorts Inc.

PK

Park Hotels & Resorts Inc.

HOLD

Current Price

$11.04

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$7.90

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PK
ADMA
Founded
1946
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
PK
ADMA
Price
$11.04
$7.90
Analyst Decision
Hold
Strong Buy
Analyst Count
9
4
Target Price
$11.22
$25.67
AVG Volume (30 Days)
4.2M
6.5M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
8.82%
N/A
EPS Growth
N/A
N/A
EPS
0.05
0.19
Revenue
$2,791,000,000.00
$42,219,783.00
Revenue This Year
$2.40
$27.46
Revenue Next Year
$2.76
$22.11
P/E Ratio
$226.30
$43.03
Revenue Growth
2.35
43.85
52 Week Low
$9.84
$7.21
52 Week High
$12.39
$22.37

Technical Indicators

Market Signals
Indicator
PK
ADMA
Relative Strength Index (RSI) 47.06 23.22
Support Level $10.85 $7.21
Resistance Level $11.79 $16.30
Average True Range (ATR) 0.34 0.55
MACD -0.03 -0.20
Stochastic Oscillator 12.70 10.76

Price Performance

Historical Comparison
PK
ADMA

About PK Park Hotels & Resorts Inc.

Park Hotels & Resorts owns upper-upscale and luxury hotels, with 21,042 rooms across 33 hotels in the United States. Park also has interests through joint ventures in another 1,712 rooms in two US hotels. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under the Hilton brand. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: